Augmentation of the lipopolysaccharide-neutralizing activities of human cathelicidin CAP18/LL-37-derived antimicrobial peptides by replacement with hydrophobic and cationic amino acid residues

被引:146
作者
Nagaoka, I
Hirota, S
Niyonsaba, F
Hirata, M
Adachi, Y
Tamura, H
Tanaka, S
Heumann, D
机构
[1] Juntendo Univ, Sch Med, Dept Biochem, Bunkyo Ku, Tokyo 1138421, Japan
[2] Tokyo Univ Pharm & Life Sci, Lab Immunopharmacol Microbial Prod, Sch Pharm, Tokyo, Japan
[3] Seikagaku Corp, Cent Res Labs, Tokyo, Japan
[4] Ctr Hosp Univ Vaudois Lausanne, Div Infect Dis, Lausanne, Switzerland
关键词
D O I
10.1128/CDLI.9.5.972-982.2002
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Mammalian myeloid and epithelial cells express various peptide antibiotics (such as defensins and cathelicidins) that contribute to the innate host defense against invading microorganisms. Among these peptides, human cathelicidin CAP18/LL-37 (L-1 to S-37) possesses not only potent antibacterial activity against gram-positive and gram-negative bacteria but also the ability to bind to gram-negative lipopolysaccharide (LPS) and neutralize its biological activities. In this study, to develop peptide derivatives with improved LPS-neutralizing activities, we utilized an 18-mer peptide (K-15; to V-32) of LL-37 as a template and evaluated the activities of modified peptides by using the CD14(+) murine macrophage cell line RAW 264.7 and the murine endotoxin shock model. By replacement of E-16 and K-25 With two L residues, the hydrophobicity of the peptide (18-mer LL) was increased, and by further replacement of Q(22), D-26, and N-30 with three K residues, the cationicity of the peptide (18-mer LLKKK) was enhanced. Among peptide derivatives, 18-mer LLKKK displayed the most powerful LPS- neutralizing activity: it was most potent at binding to LPS, inhibiting the interaction between LPS and LPS-binding protein, and attaching to the CD14 molecule, thereby suppressing the binding of LPS to CD14(+) cells and attenuating production of tumor necrosis factor alpha (TNF-alpha) by these cells. Furthermore, in the murine endotoxin shock model, 18-mer LLKKK most effectively suppressed LPS-induced TNF-alpha production and protected mice from lethal endotoxin shock. Together, these observations indicate that the LPS-neutralizing activities of the amphipathic human CAP18LL-37-derived 18-mer peptide can be augmented by modifying its hydrophobicity and cationicity, and that 18-mer LLKKK is the most potent of the peptide derivatives, with therapeutic potential for gram-negative bacterial endotoxin shock.
引用
收藏
页码:972 / 982
页数:11
相关论文
共 53 条
[1]   Inhibition by a CD14 monoclonal antibody of lipopolysaccharide binding to murine macrophages [J].
Adachi, Y ;
Satokawa, C ;
Saeki, M ;
Ohno, N ;
Tamura, H ;
Tanaka, S ;
Yadomae, T .
JOURNAL OF ENDOTOXIN RESEARCH, 1999, 5 (03) :139-146
[2]   Toll-like receptors in the induction of the innate immune response [J].
Aderem, A ;
Ulevitch, RJ .
NATURE, 2000, 406 (6797) :782-787
[3]   PASSIVE-IMMUNIZATION AGAINST CACHECTIN TUMOR NECROSIS FACTOR PROTECTS MICE FROM LETHAL EFFECT OF ENDOTOXIN [J].
BEUTLER, B ;
MILSARK, IW ;
CERAMI, AC .
SCIENCE, 1985, 229 (4716) :869-871
[4]   Toll-like receptors: molecular mechanisms of the mammalian immune response [J].
Brightbill, HD ;
Modlin, RL .
IMMUNOLOGY, 2000, 101 (01) :1-10
[5]  
BUCKLIN SE, 1994, J ENDOTOXIN RES, V1, P45
[6]   Synthetic endotoxin-binding peptides block endotoxin-triggered TNF-α production by macrophages in vitro and in vivo and prevent endotoxin-mediated toxic shock [J].
Dankesreiter, S ;
Hoess, A ;
Schneider-Mergener, J ;
Wagner, H ;
Miethke, T .
JOURNAL OF IMMUNOLOGY, 2000, 164 (09) :4804-4811
[7]   LPS-binding proteins and receptors [J].
Fenton, MJ ;
Golenbock, DT .
JOURNAL OF LEUKOCYTE BIOLOGY, 1998, 64 (01) :25-32
[8]   GALACTOSAMINE-INDUCED SENSITIZATION TO THE LETHAL EFFECTS OF ENDOTOXIN [J].
GALANOS, C ;
FREUDENBERG, MA ;
REUTTER, W .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1979, 76 (11) :5939-5943
[9]  
Gennaro R, 2000, BIOPOLYMERS, V55, P31, DOI 10.1002/1097-0282(2000)55:1<31::AID-BIP40>3.0.CO
[10]  
2-9